Eryngium caeruleum: an update on ethnobotany, phytochemistry and biomedical applications.

Abstract

BACKGROUND:

A biennial or perennial plant of the Apiaceae family, Eryngium caeruleum M. Bieb. is traditionally used in medicine as an antitoxic, diuretic, digestive, anti-inflammatory and analgesic drug. This plant is widely distributed in temperate regions around the world. Young leaves of the plant are used in cooking as aromatic cooked vegetables in various local products in Iran.

PURPOSE:

The current review aimed to highlight complete and updated information about the Eryngium caeruleum species, regarding botanical, ethnopharmacological, phytochemical data, pharmacological mechanisms as well as some nutritional properties. All this scientific evidence supports the use of this species in complementary medicine, thus opening new therapeutic perspectives for the treatment of some diseases.

METHODS:

The information provided in this updated review is collected from several scientific databases such as PubMed/Medline, ScienceDirect, Mendeley, Scopus, Web of Science and Google Scholar. Ethnopharmacology books and various professional websites were also researched.

RESULTS:

The phytochemical composition of the aerial parts and roots of E. caeruleum is represented by the components of essential oil (EO), phenolic compounds, saponins, protein, amino acids, fiber, carbohydrates, and mineral elements. The antioxidant, antimicrobial, antidiabetic, antihypoxic, and anti-inflammatory properties of E. caeruleum have been confirmed by pharmacological experiments with extracts using in vitro and in vivo methods. The syrup E. caeruleum relieved dysmenorrhea as effectively as Ibuprofen in the blinded, randomized, placebo-controlled clinical study.

CONCLUSION:

Current evidence from experimental pharmacological studies has shown that the different bioactive compounds present in the species E. caeruleum have multiple beneficial effects on human health, being potentially active in the treatment of many diseases. Thus, the traditional uses of this species are supported based on evidence. In future, translational and human clinical studies are necessary to establish effective therapeutic doses in humans.

• Authors: Dmitryi Alexeevich Konovalov, Edgardo Avendaño Cáceres, Ekaterina Aleksandrovna Shcherbakova, Jesús Herrera-Bravo, Deepak Chandran, Miquel Martorell, Muzaffar Hasan, Manoj Kumar, Saad Bakrim, Abdelhakim Bouyahya, William C Cho, Javad Sharifi-Rad, Hafiz A R Suleria, Daniela Calina
• Journal: Chinese medicine (Chin Med) Vol. 17 Issue 1 Pg. 114 (Sep 29 2022) ISSN: 1749-8546 [Print] England
• PMID: 36175969 (Publication Type: Journal Article, Review)
• Copyright: © 2022. The Author(s).